Autres langues Regeneron Pharmaceuticals, Inc.

Actions

REGN

US75886F1075

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 24/05/2024			Varia. 5j.	Varia. 1 janv.
985 ^USD	+0,45 %		+0,28 %	+12,15 %

23/05	Regeneron Pharmaceuticals annonce que le GN7075 et le Libtayo montrent des réponses anti-tumorales dans le cancer colorectal stable au niveau des microsatellites	MT
23/05	Regeneron Pharmaceuticals, Inc. Annonce de nouveaux résultats positifs d'un essai de phase 1/2 en cours évaluant son anticorps bispécifique costimulant de première classe, REGN7075 (EGFRxCD28)	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Regeneron Pharmaceuticals Says GN7075 Plus Libtayo Shows Anti-Tumor Responses in Microsatellite Stable Colorectal Cancer	23/05
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO	23/05
Regeneron Pharmaceuticals, Inc. Announces Positive New Results from an Ongoing Phase 1/2 Trial Evaluating its First-in-Class Costimulatory Bispecific Antibody, REGN7075	23/05
ETF de la semana: Los “utilities” desempeñan un papel en la aparición del AII	23/05
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN	22/05
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,855,489, According to a Recent SEC Filing	22/05
Regeneron, Sanofi Disclose Positive Results for Lung Disease Treatment Candidate	20/05
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine	20/05
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine	20/05
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024	20/05
Compañías que se deben tener muy en cuenta por técnico este lunes en Wall Street	20/05
Regeneron Pharmaceuticals Insider Sold Shares Worth $22,355,714, According to a Recent SEC Filing	18/05
Regeneron Pharmaceuticals Insider Sold Shares Worth $48,636,545, According to a Recent SEC Filing	17/05
Sector Update: Health Care Stocks Mixed Late Afternoon	17/05
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024	17/05
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Regeneron Pharmaceuticals, Inc. (REGN)	16/05
ETF de la semana: India y Brasil podrían despertar	16/05
Regeneron Pharmaceuticals Insider Sold Shares Worth $35,207,110, According to a Recent SEC Filing	16/05
MIDDAY BRIEFING - Unternehmen und Märkte -2-	13/05
FDA prüft Antrag von Regeneron und Sanofi für Dupixent vorrangig	13/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Regeneron Pharmaceuticals, Inc.

Actions

REGN

US75886F1075

Autres langues

Filtres